Menu

Tax Services for the Life Sciences Industry

Identifying opportunities to minimize tax and compliance burdens

Life sciences companies face a variety of tax considerations from the affects of tax reform to the benefits of R&D credits, to intellectual property planning and global reporting and compliance. Proper tax planning is imperative in order to avoid unnecessary tax exposure and minimize risk. 

RSM’s tax professionals provide specific life sciences tax consulting to companies on a variety of tax matters that include credits and incentives, state and local issues, and international tax planning.

RELATED INSIGHTS

INSIGHT ARTICLE

Life sciences 2018 tax year in review—and a look ahead

Tax highlights for life sciences companies as you prepare for year-end filing and a look ahead to prepare for 2019.

INSIGHT ARTICLE

Tax-free spin offs prior to product sales stage could become a reality

The IRS is reconsidering the traditional rule requiring revenue to satisfy the active trade or business requirement of section 355.

CASE STUDY

With basic functions improved, a company can focus on strategy

Covance, a life sciences company, wanted to improve its approach to managing global reporting and compliance requirements.

INSIGHT ARTICLE

IRS legal advice requires capitalization of ANDA costs

A review of IRS rulings on the proper treatment of similar expenses that were incurred by a pharmaceutical company.

INSIGHT ARTICLE

New York offers life science companies research and development credit

New life sciences businesses can earn up to a maximum tax benefit of $1.5 million in tax credits over three years.